

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.65972957 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.60459276 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.56749896 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.32448188 |
| 5 | protein localization to synapse (GO:0035418) | 5.25486722 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.23287182 |
| 7 | neuronal action potential propagation (GO:0019227) | 4.92506158 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.84942544 |
| 9 | glutamate secretion (GO:0014047) | 4.81126088 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.77427773 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.61794691 |
| 12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.60701529 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.57438065 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51951567 |
| 15 | glutamate receptor signaling pathway (GO:0007215) | 4.40475844 |
| 16 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.31391950 |
| 17 | presynaptic membrane assembly (GO:0097105) | 4.30909038 |
| 18 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.25293842 |
| 19 | neuron-neuron synaptic transmission (GO:0007270) | 4.21258152 |
| 20 | dopamine transport (GO:0015872) | 4.19268913 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.15325556 |
| 22 | locomotory exploration behavior (GO:0035641) | 4.12980903 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.11151507 |
| 24 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.10319328 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.09269350 |
| 26 | synaptic vesicle maturation (GO:0016188) | 4.01687420 |
| 27 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.01682585 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 4.00306093 |
| 29 | neurotransmitter secretion (GO:0007269) | 3.99319696 |
| 30 | neuron recognition (GO:0008038) | 3.96715312 |
| 31 | presynaptic membrane organization (GO:0097090) | 3.96175625 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.91364858 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.87968607 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.87706316 |
| 35 | exploration behavior (GO:0035640) | 3.84083488 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.83793013 |
| 37 | tachykinin receptor signaling pathway (GO:0007217) | 3.80404912 |
| 38 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.79372005 |
| 39 | proline transport (GO:0015824) | 3.76427508 |
| 40 | retinal cone cell development (GO:0046549) | 3.75617451 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.75409941 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.73955570 |
| 43 | long-term synaptic potentiation (GO:0060291) | 3.68457353 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.66849027 |
| 45 | detection of calcium ion (GO:0005513) | 3.66818245 |
| 46 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.65552347 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.63389910 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.62932815 |
| 49 | startle response (GO:0001964) | 3.62449651 |
| 50 | piRNA metabolic process (GO:0034587) | 3.61987591 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.60749993 |
| 52 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.54797641 |
| 53 | regulation of neurotransmitter uptake (GO:0051580) | 3.53779492 |
| 54 | response to histamine (GO:0034776) | 3.52148521 |
| 55 | ketone body metabolic process (GO:1902224) | 3.51761441 |
| 56 | transmission of nerve impulse (GO:0019226) | 3.50084263 |
| 57 | regulation of synaptic plasticity (GO:0048167) | 3.49900320 |
| 58 | regulation of glutamate secretion (GO:0014048) | 3.44049033 |
| 59 | peristalsis (GO:0030432) | 3.43650232 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.43137106 |
| 61 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.42585216 |
| 62 | neurotransmitter transport (GO:0006836) | 3.39700475 |
| 63 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.38683422 |
| 64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.37168526 |
| 65 | axonal fasciculation (GO:0007413) | 3.35766436 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.35606381 |
| 67 | layer formation in cerebral cortex (GO:0021819) | 3.31771572 |
| 68 | photoreceptor cell maintenance (GO:0045494) | 3.30899055 |
| 69 | respiratory chain complex IV assembly (GO:0008535) | 3.30495840 |
| 70 | behavioral defense response (GO:0002209) | 3.30205219 |
| 71 | behavioral fear response (GO:0001662) | 3.30205219 |
| 72 | membrane depolarization (GO:0051899) | 3.29609326 |
| 73 | protein localization to cilium (GO:0061512) | 3.27727496 |
| 74 | negative regulation of dendrite development (GO:2000171) | 3.26858093 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.26847024 |
| 76 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.24774076 |
| 77 | detection of light stimulus involved in visual perception (GO:0050908) | 3.24774076 |
| 78 | long-term memory (GO:0007616) | 3.24187233 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22110453 |
| 80 | axoneme assembly (GO:0035082) | 3.21593651 |
| 81 | protein K11-linked deubiquitination (GO:0035871) | 3.20071636 |
| 82 | serotonin metabolic process (GO:0042428) | 3.18496965 |
| 83 | neuronal action potential (GO:0019228) | 3.18415131 |
| 84 | membrane depolarization during action potential (GO:0086010) | 3.17706043 |
| 85 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.16741036 |
| 86 | epithelial cilium movement (GO:0003351) | 3.15637086 |
| 87 | positive regulation of synapse assembly (GO:0051965) | 3.15514034 |
| 88 | regulation of synapse maturation (GO:0090128) | 3.15381521 |
| 89 | behavioral response to cocaine (GO:0048148) | 3.15358066 |
| 90 | serotonin receptor signaling pathway (GO:0007210) | 3.13675483 |
| 91 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.13636934 |
| 92 | synapse assembly (GO:0007416) | 3.12542544 |
| 93 | innervation (GO:0060384) | 3.12024929 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 3.11281534 |
| 95 | DNA methylation involved in gamete generation (GO:0043046) | 3.09675971 |
| 96 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.09607416 |
| 97 | learning (GO:0007612) | 3.09260166 |
| 98 | regulation of neurotransmitter levels (GO:0001505) | 3.09149821 |
| 99 | auditory receptor cell stereocilium organization (GO:0060088) | 3.09036552 |
| 100 | primary amino compound metabolic process (GO:1901160) | 3.08538769 |
| 101 | fear response (GO:0042596) | 3.08280049 |
| 102 | female mating behavior (GO:0060180) | 3.08095768 |
| 103 | regulation of female receptivity (GO:0045924) | 3.07743973 |
| 104 | phasic smooth muscle contraction (GO:0014821) | 3.07636706 |
| 105 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.07354416 |
| 106 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.07354416 |
| 107 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.07266616 |
| 108 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.06865899 |
| 109 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.06865899 |
| 110 | striatum development (GO:0021756) | 3.05916871 |
| 111 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.05782582 |
| 112 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.05502805 |
| 113 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.04548257 |
| 114 | synaptic transmission (GO:0007268) | 3.04118979 |
| 115 | behavioral response to nicotine (GO:0035095) | 3.03116938 |
| 116 | multicellular organism reproduction (GO:0032504) | 3.03085400 |
| 117 | membrane hyperpolarization (GO:0060081) | 3.01761525 |
| 118 | indole-containing compound metabolic process (GO:0042430) | 3.01229107 |
| 119 | dendritic spine morphogenesis (GO:0060997) | 2.98637494 |
| 120 | regulation of hexokinase activity (GO:1903299) | 2.98040108 |
| 121 | regulation of glucokinase activity (GO:0033131) | 2.98040108 |
| 122 | regulation of synaptic transmission (GO:0050804) | 2.97596022 |
| 123 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97452393 |
| 124 | establishment of synaptic vesicle localization (GO:0097480) | 2.96485407 |
| 125 | synaptic vesicle transport (GO:0048489) | 2.96485407 |
| 126 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.96406328 |
| 127 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.96406328 |
| 128 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.95893623 |
| 129 | positive regulation of neurotransmitter transport (GO:0051590) | 2.95587567 |
| 130 | long term synaptic depression (GO:0060292) | 2.93972756 |
| 131 | transferrin transport (GO:0033572) | 2.93347997 |
| 132 | indolalkylamine metabolic process (GO:0006586) | 2.91694648 |
| 133 | regulation of neurotransmitter transport (GO:0051588) | 2.91585148 |
| 134 | intraspecies interaction between organisms (GO:0051703) | 2.90876379 |
| 135 | social behavior (GO:0035176) | 2.90876379 |
| 136 | endocrine pancreas development (GO:0031018) | 2.90569135 |
| 137 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89955459 |
| 138 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.89081192 |
| 139 | cellular potassium ion homeostasis (GO:0030007) | 2.87526022 |
| 140 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.86300648 |
| 141 | tryptophan catabolic process (GO:0006569) | 2.85561706 |
| 142 | indole-containing compound catabolic process (GO:0042436) | 2.85561706 |
| 143 | indolalkylamine catabolic process (GO:0046218) | 2.85561706 |
| 144 | neuron fate determination (GO:0048664) | 2.83994195 |
| 145 | reflex (GO:0060004) | 2.82694472 |
| 146 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.80550104 |
| 147 | nephron epithelium morphogenesis (GO:0072088) | 2.80294962 |
| 148 | nephron tubule morphogenesis (GO:0072078) | 2.80294962 |
| 149 | nonmotile primary cilium assembly (GO:0035058) | 2.79562526 |
| 150 | xenobiotic catabolic process (GO:0042178) | 2.78929554 |
| 151 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.78794801 |
| 152 | signal peptide processing (GO:0006465) | 2.78473278 |
| 153 | catecholamine transport (GO:0051937) | 2.78412085 |
| 154 | dentate gyrus development (GO:0021542) | 2.77642873 |
| 155 | cilium movement (GO:0003341) | 2.77374242 |
| 156 | adaptation of signaling pathway (GO:0023058) | 2.76856275 |
| 157 | protein-chromophore linkage (GO:0018298) | 2.76263502 |
| 158 | inner ear receptor stereocilium organization (GO:0060122) | 2.75535666 |
| 159 | C4-dicarboxylate transport (GO:0015740) | 2.74040046 |
| 160 | L-fucose catabolic process (GO:0042355) | 2.73146477 |
| 161 | fucose catabolic process (GO:0019317) | 2.73146477 |
| 162 | L-fucose metabolic process (GO:0042354) | 2.73146477 |
| 163 | adult walking behavior (GO:0007628) | 2.72496678 |
| 164 | prepulse inhibition (GO:0060134) | 2.72167209 |
| 165 | peptidyl-histidine modification (GO:0018202) | 2.70824140 |
| 166 | parental behavior (GO:0060746) | 2.70086348 |
| 167 | magnesium ion transport (GO:0015693) | 2.68195477 |
| 168 | rhodopsin mediated signaling pathway (GO:0016056) | 2.66901471 |
| 169 | renal tubule morphogenesis (GO:0061333) | 2.65288554 |
| 170 | auditory receptor cell differentiation (GO:0042491) | 2.63076609 |
| 171 | protein polyglutamylation (GO:0018095) | 2.62602293 |
| 172 | alanine transport (GO:0032328) | 2.62515759 |
| 173 | cilium organization (GO:0044782) | 2.60182889 |
| 174 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.60122116 |
| 175 | regulation of cilium movement (GO:0003352) | 2.59460853 |
| 176 | maternal behavior (GO:0042711) | 2.58716272 |
| 177 | cytochrome complex assembly (GO:0017004) | 2.58419509 |
| 178 | cilium assembly (GO:0042384) | 2.57064437 |
| 179 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.56264454 |
| 180 | regulation of meiosis I (GO:0060631) | 2.55733398 |
| 181 | mannosylation (GO:0097502) | 2.54706889 |
| 182 | behavioral response to ethanol (GO:0048149) | 2.53509575 |
| 183 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.51542651 |
| 184 | righting reflex (GO:0060013) | 2.51342817 |
| 185 | glycerophospholipid catabolic process (GO:0046475) | 2.49550700 |
| 186 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.48292601 |
| 187 | multicellular organismal signaling (GO:0035637) | 2.46416044 |
| 188 | photoreceptor cell development (GO:0042461) | 2.44351785 |
| 189 | neural tube formation (GO:0001841) | 2.41486155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.42389389 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.21705972 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16093913 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07618066 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.96908782 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96051592 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.74248318 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66796480 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55449176 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53163147 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50234190 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50234190 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44883203 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44668380 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43152057 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34685983 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.32662724 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32019821 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30734137 |
| 20 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.21293916 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19171955 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02581516 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00450497 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00089858 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99712903 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99690939 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.98814382 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96601643 |
| 29 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.96067721 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94778296 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.92719964 |
| 32 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.88182532 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87880944 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82094429 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80881564 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78364900 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76579642 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.75908171 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74455832 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67911647 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.65158498 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60241697 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56987013 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.56889981 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56527355 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55872418 |
| 47 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52963924 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50860018 |
| 49 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47827890 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47765806 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47765806 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47454597 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46855088 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46015129 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45434484 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45020327 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43671683 |
| 58 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.41379564 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40864146 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38263101 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37590432 |
| 62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37334222 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35737503 |
| 64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.35426536 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35263227 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32825798 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31592596 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31343944 |
| 69 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29860554 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29823876 |
| 71 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27852765 |
| 72 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27817325 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.26903358 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24260099 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23568568 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22028697 |
| 77 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21942509 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20544152 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19683761 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19683761 |
| 81 | JUN_21703547_ChIP-Seq_K562_Human | 1.19439211 |
| 82 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18987958 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18863557 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18611415 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17510820 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16070003 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15666343 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15494968 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15475669 |
| 90 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14433222 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13225440 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12920960 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11888097 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11888097 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10906027 |
| 96 | AR_19668381_ChIP-Seq_PC3_Human | 1.10366810 |
| 97 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10177496 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10160563 |
| 99 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09894640 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09341832 |
| 101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09341832 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09291251 |
| 103 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.08824411 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08609688 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08202286 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08039148 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07900920 |
| 108 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06832722 |
| 109 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05789328 |
| 110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05172052 |
| 111 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04309174 |
| 112 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04006447 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03602865 |
| 114 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03346390 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03250405 |
| 116 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02279196 |
| 117 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02050923 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01679766 |
| 119 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01580621 |
| 120 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00970793 |
| 121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99715310 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98427610 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97707490 |
| 124 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97452441 |
| 125 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97143166 |
| 126 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96514511 |
| 127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96119226 |
| 128 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95891687 |
| 129 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95456738 |
| 130 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94977869 |
| 131 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94097757 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93995905 |
| 133 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93959214 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92672941 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92334799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.55998919 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.50523729 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.99528892 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.87474738 |
| 5 | MP0002736_abnormal_nociception_after | 3.46868293 |
| 6 | MP0004270_analgesia | 3.44881172 |
| 7 | MP0009745_abnormal_behavioral_response | 3.44148123 |
| 8 | MP0002064_seizures | 3.24836954 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.17953874 |
| 10 | MP0002735_abnormal_chemical_nociception | 3.15652909 |
| 11 | MP0009046_muscle_twitch | 3.01272103 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.85255914 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.80151925 |
| 14 | MP0002272_abnormal_nervous_system | 2.74277543 |
| 15 | MP0001486_abnormal_startle_reflex | 2.51192564 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.48440927 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.46395145 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.45058715 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.39593109 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.29658692 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.22327265 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.22271742 |
| 23 | MP0001970_abnormal_pain_threshold | 2.17741753 |
| 24 | MP0002822_catalepsy | 2.08119664 |
| 25 | MP0008057_abnormal_DNA_replication | 1.95184032 |
| 26 | MP0002184_abnormal_innervation | 1.94013778 |
| 27 | MP0004043_abnormal_pH_regulation | 1.89634800 |
| 28 | MP0003329_amyloid_beta_deposits | 1.85567103 |
| 29 | MP0000778_abnormal_nervous_system | 1.83636317 |
| 30 | MP0003136_yellow_coat_color | 1.83244294 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.80589548 |
| 32 | MP0001984_abnormal_olfaction | 1.79553727 |
| 33 | MP0005253_abnormal_eye_physiology | 1.75974218 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.70806281 |
| 35 | MP0004133_heterotaxia | 1.69397235 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.68308859 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.65543998 |
| 38 | MP0004924_abnormal_behavior | 1.65543998 |
| 39 | MP0000383_abnormal_hair_follicle | 1.65191615 |
| 40 | MP0003195_calcinosis | 1.64336549 |
| 41 | MP0003879_abnormal_hair_cell | 1.64281996 |
| 42 | MP0001188_hyperpigmentation | 1.60043332 |
| 43 | MP0000427_abnormal_hair_cycle | 1.56070765 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.53017693 |
| 45 | MP0008569_lethality_at_weaning | 1.50618743 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.50385003 |
| 47 | MP0001529_abnormal_vocalization | 1.50247813 |
| 48 | MP0001905_abnormal_dopamine_level | 1.49687098 |
| 49 | MP0003646_muscle_fatigue | 1.47893398 |
| 50 | MP0000955_abnormal_spinal_cord | 1.46850963 |
| 51 | MP0004142_abnormal_muscle_tone | 1.43241782 |
| 52 | MP0002163_abnormal_gland_morphology | 1.40123647 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.36737046 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.35900934 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.35829867 |
| 56 | MP0004858_abnormal_nervous_system | 1.35267667 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.31929691 |
| 58 | MP0001944_abnormal_pancreas_morphology | 1.28748439 |
| 59 | MP0002653_abnormal_ependyma_morphology | 1.28018455 |
| 60 | MP0003787_abnormal_imprinting | 1.27538807 |
| 61 | MP0002928_abnormal_bile_duct | 1.25620887 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.23738585 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.20863136 |
| 64 | MP0004742_abnormal_vestibular_system | 1.19315546 |
| 65 | MP0002909_abnormal_adrenal_gland | 1.18831859 |
| 66 | MP0000372_irregular_coat_pigmentation | 1.17596564 |
| 67 | MP0003122_maternal_imprinting | 1.16946256 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 1.16440403 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 1.11016901 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.06906148 |
| 71 | MP0001963_abnormal_hearing_physiology | 1.06751716 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.04476240 |
| 73 | MP0010329_abnormal_lipoprotein_level | 1.04141291 |
| 74 | MP0002160_abnormal_reproductive_system | 1.03448681 |
| 75 | MP0003633_abnormal_nervous_system | 1.02613781 |
| 76 | MP0002693_abnormal_pancreas_physiology | 1.01636991 |
| 77 | MP0003718_maternal_effect | 1.01266684 |
| 78 | MP0002234_abnormal_pharynx_morphology | 1.00775384 |
| 79 | MP0004885_abnormal_endolymph | 1.00746271 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00710319 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.99396202 |
| 82 | MP0001764_abnormal_homeostasis | 0.98080430 |
| 83 | MP0002152_abnormal_brain_morphology | 0.97971863 |
| 84 | MP0002229_neurodegeneration | 0.97308211 |
| 85 | MP0003631_nervous_system_phenotype | 0.96309373 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.95620750 |
| 87 | MP0004484_altered_response_of | 0.95074095 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.92913675 |
| 89 | MP0005332_abnormal_amino_acid | 0.92551185 |
| 90 | MP0005389_reproductive_system_phenotype | 0.92107330 |
| 91 | MP0001756_abnormal_urination | 0.91971456 |
| 92 | MP0004147_increased_porphyrin_level | 0.91826979 |
| 93 | MP0008874_decreased_physiological_sensi | 0.90394333 |
| 94 | MP0000751_myopathy | 0.89111343 |
| 95 | MP0005171_absent_coat_pigmentation | 0.88085284 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.87829684 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.86439814 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.86335254 |
| 99 | MP0005499_abnormal_olfactory_system | 0.86335254 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.86278680 |
| 101 | MP0005195_abnormal_posterior_eye | 0.86073353 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.85995608 |
| 103 | MP0000604_amyloidosis | 0.84683898 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.84198152 |
| 105 | MP0005085_abnormal_gallbladder_physiolo | 0.82603229 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 0.82193640 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.82026110 |
| 108 | MP0003698_abnormal_male_reproductive | 0.80802525 |
| 109 | MP0004085_abnormal_heartbeat | 0.80800342 |
| 110 | MP0003121_genomic_imprinting | 0.79578738 |
| 111 | MP0004215_abnormal_myocardial_fiber | 0.79325831 |
| 112 | MP0001664_abnormal_digestion | 0.76688822 |
| 113 | MP0008872_abnormal_physiological_respon | 0.74991844 |
| 114 | MP0003632_abnormal_nervous_system | 0.74620851 |
| 115 | MP0005535_abnormal_body_temperature | 0.72837746 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.71836294 |
| 117 | MP0000026_abnormal_inner_ear | 0.70252276 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.70124105 |
| 119 | MP0003634_abnormal_glial_cell | 0.67965542 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.67928390 |
| 121 | MP0002751_abnormal_autonomic_nervous | 0.66646360 |
| 122 | MP0001177_atelectasis | 0.64359630 |
| 123 | MP0010234_abnormal_vibrissa_follicle | 0.64120900 |
| 124 | MP0005409_darkened_coat_color | 0.63325498 |
| 125 | MP0000920_abnormal_myelination | 0.60421785 |
| 126 | MP0002090_abnormal_vision | 0.59152225 |
| 127 | MP0005379_endocrine/exocrine_gland_phen | 0.58645378 |
| 128 | MP0006292_abnormal_olfactory_placode | 0.58370229 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.57368995 |
| 130 | MP0002102_abnormal_ear_morphology | 0.55931397 |
| 131 | MP0004510_myositis | 0.55536531 |
| 132 | MP0005410_abnormal_fertilization | 0.55135879 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.53134907 |
| 134 | MP0001943_abnormal_respiration | 0.49632476 |
| 135 | MP0010770_preweaning_lethality | 0.48120491 |
| 136 | MP0002082_postnatal_lethality | 0.48120491 |
| 137 | MP0003938_abnormal_ear_development | 0.46653217 |
| 138 | MP0006072_abnormal_retinal_apoptosis | 0.46290309 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.45878599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.82560927 |
| 2 | Focal seizures (HP:0007359) | 6.07618828 |
| 3 | Atonic seizures (HP:0010819) | 5.70429999 |
| 4 | Visual hallucinations (HP:0002367) | 5.44692635 |
| 5 | Myokymia (HP:0002411) | 5.15024062 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.03986552 |
| 7 | Febrile seizures (HP:0002373) | 4.86035943 |
| 8 | Hyperventilation (HP:0002883) | 4.84240725 |
| 9 | Absence seizures (HP:0002121) | 4.73671858 |
| 10 | Dialeptic seizures (HP:0011146) | 4.59703373 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.07069078 |
| 12 | Congenital stationary night blindness (HP:0007642) | 3.97808675 |
| 13 | True hermaphroditism (HP:0010459) | 3.97483122 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.93764931 |
| 15 | Pancreatic fibrosis (HP:0100732) | 3.75112520 |
| 16 | Pancreatic cysts (HP:0001737) | 3.64516993 |
| 17 | Broad-based gait (HP:0002136) | 3.50975397 |
| 18 | Attenuation of retinal blood vessels (HP:0007843) | 3.46915488 |
| 19 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.46705090 |
| 20 | Amblyopia (HP:0000646) | 3.25714141 |
| 21 | Congenital sensorineural hearing impairment (HP:0008527) | 3.10430528 |
| 22 | Abnormality of the renal cortex (HP:0011035) | 3.07178332 |
| 23 | Intestinal atresia (HP:0011100) | 3.06808702 |
| 24 | Drooling (HP:0002307) | 3.06214776 |
| 25 | Excessive salivation (HP:0003781) | 3.06214776 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.03486455 |
| 27 | Cerebral inclusion bodies (HP:0100314) | 3.03400811 |
| 28 | Renal cortical cysts (HP:0000803) | 3.00665838 |
| 29 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.96549861 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.94753074 |
| 31 | Oligodactyly (hands) (HP:0001180) | 2.94366832 |
| 32 | Absent speech (HP:0001344) | 2.90627666 |
| 33 | Tubular atrophy (HP:0000092) | 2.86920083 |
| 34 | Molar tooth sign on MRI (HP:0002419) | 2.86826128 |
| 35 | Abnormality of midbrain morphology (HP:0002418) | 2.86826128 |
| 36 | Poor eye contact (HP:0000817) | 2.83291626 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 2.79547336 |
| 38 | Progressive inability to walk (HP:0002505) | 2.73329762 |
| 39 | Truncal ataxia (HP:0002078) | 2.72906558 |
| 40 | Nephronophthisis (HP:0000090) | 2.71539433 |
| 41 | Action tremor (HP:0002345) | 2.69622513 |
| 42 | Gait imbalance (HP:0002141) | 2.68721810 |
| 43 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.67714071 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.67322070 |
| 45 | Abnormal social behavior (HP:0012433) | 2.65118761 |
| 46 | Impaired social interactions (HP:0000735) | 2.65118761 |
| 47 | Cystic liver disease (HP:0006706) | 2.64494826 |
| 48 | Dysmetria (HP:0001310) | 2.64399367 |
| 49 | Protruding tongue (HP:0010808) | 2.62808322 |
| 50 | EEG with generalized epileptiform discharges (HP:0011198) | 2.58283102 |
| 51 | Inability to walk (HP:0002540) | 2.54496668 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.54179178 |
| 53 | Papilledema (HP:0001085) | 2.52237921 |
| 54 | Depression (HP:0000716) | 2.50409535 |
| 55 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.49221773 |
| 56 | Acute necrotizing encephalopathy (HP:0006965) | 2.46189629 |
| 57 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.45873416 |
| 58 | Abnormal eating behavior (HP:0100738) | 2.45835071 |
| 59 | Delusions (HP:0000746) | 2.45395154 |
| 60 | Limb dystonia (HP:0002451) | 2.45179851 |
| 61 | Pheochromocytoma (HP:0002666) | 2.43263210 |
| 62 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.42957475 |
| 63 | Anxiety (HP:0000739) | 2.42646416 |
| 64 | Termporal pattern (HP:0011008) | 2.41363496 |
| 65 | Insidious onset (HP:0003587) | 2.41363496 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.39533503 |
| 67 | Sclerocornea (HP:0000647) | 2.39067170 |
| 68 | Horizontal nystagmus (HP:0000666) | 2.38065452 |
| 69 | Abnormality of the renal medulla (HP:0100957) | 2.37932782 |
| 70 | Polyphagia (HP:0002591) | 2.37552453 |
| 71 | Hypsarrhythmia (HP:0002521) | 2.36852390 |
| 72 | Constricted visual fields (HP:0001133) | 2.36534990 |
| 73 | Scanning speech (HP:0002168) | 2.36330648 |
| 74 | Abnormal hair whorl (HP:0010721) | 2.34788383 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.34569153 |
| 76 | Diplopia (HP:0000651) | 2.34569153 |
| 77 | Spastic gait (HP:0002064) | 2.34186952 |
| 78 | Ankle clonus (HP:0011448) | 2.33601061 |
| 79 | Severe visual impairment (HP:0001141) | 2.32873016 |
| 80 | Progressive macrocephaly (HP:0004481) | 2.32423779 |
| 81 | Congenital primary aphakia (HP:0007707) | 2.31599373 |
| 82 | Decreased circulating renin level (HP:0003351) | 2.29843589 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.29068367 |
| 84 | Abnormality of the corticospinal tract (HP:0002492) | 2.27679771 |
| 85 | Status epilepticus (HP:0002133) | 2.25649657 |
| 86 | Medial flaring of the eyebrow (HP:0010747) | 2.24627458 |
| 87 | Furrowed tongue (HP:0000221) | 2.23726732 |
| 88 | Blue irides (HP:0000635) | 2.23033011 |
| 89 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.21401749 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.20284953 |
| 91 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.20217057 |
| 92 | Genital tract atresia (HP:0001827) | 2.19813818 |
| 93 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18908202 |
| 94 | Bradykinesia (HP:0002067) | 2.18466225 |
| 95 | Retinal dysplasia (HP:0007973) | 2.18308269 |
| 96 | Abnormality of salivation (HP:0100755) | 2.17743698 |
| 97 | Polydipsia (HP:0001959) | 2.17221272 |
| 98 | Abnormal drinking behavior (HP:0030082) | 2.17221272 |
| 99 | Genetic anticipation (HP:0003743) | 2.16675353 |
| 100 | Hemiparesis (HP:0001269) | 2.16441370 |
| 101 | Mutism (HP:0002300) | 2.16214217 |
| 102 | Postural instability (HP:0002172) | 2.15887556 |
| 103 | Optic nerve hypoplasia (HP:0000609) | 2.15237334 |
| 104 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.14628288 |
| 105 | Vaginal atresia (HP:0000148) | 2.13338582 |
| 106 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13313737 |
| 107 | Fair hair (HP:0002286) | 2.13291200 |
| 108 | Postaxial hand polydactyly (HP:0001162) | 2.09186249 |
| 109 | Retinitis pigmentosa (HP:0000510) | 2.08326920 |
| 110 | Widely spaced teeth (HP:0000687) | 2.08142653 |
| 111 | Poor coordination (HP:0002370) | 2.07913831 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 2.07722443 |
| 113 | Chronic hepatic failure (HP:0100626) | 2.06946677 |
| 114 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.06897236 |
| 115 | Hypoplasia of the fovea (HP:0007750) | 2.06897236 |
| 116 | Pendular nystagmus (HP:0012043) | 2.06859883 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.06837315 |
| 118 | Generalized hypopigmentation of hair (HP:0011358) | 2.06609422 |
| 119 | Abnormal ciliary motility (HP:0012262) | 2.05658531 |
| 120 | Urinary urgency (HP:0000012) | 2.04484290 |
| 121 | Abnormality of the labia minora (HP:0012880) | 1.98693434 |
| 122 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98228246 |
| 123 | Large for gestational age (HP:0001520) | 1.97549606 |
| 124 | Hyperthyroidism (HP:0000836) | 1.96256911 |
| 125 | Impaired smooth pursuit (HP:0007772) | 1.95852482 |
| 126 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.95848043 |
| 127 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.95848043 |
| 128 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.94660458 |
| 129 | Gastrointestinal atresia (HP:0002589) | 1.93506563 |
| 130 | Oligodactyly (HP:0012165) | 1.92544269 |
| 131 | Specific learning disability (HP:0001328) | 1.90620816 |
| 132 | Psychosis (HP:0000709) | 1.90466249 |
| 133 | Akinesia (HP:0002304) | 1.89270630 |
| 134 | Hypoalbuminemia (HP:0003073) | 1.88377195 |
| 135 | Abnormal albumin level (HP:0012116) | 1.88377195 |
| 136 | Glycosuria (HP:0003076) | 1.87932952 |
| 137 | Abnormality of urine glucose concentration (HP:0011016) | 1.87932952 |
| 138 | Impaired vibratory sensation (HP:0002495) | 1.87160902 |
| 139 | Thickened helices (HP:0000391) | 1.87096614 |
| 140 | Mitochondrial inheritance (HP:0001427) | 1.86330816 |
| 141 | Decreased central vision (HP:0007663) | 1.85114451 |
| 142 | Abnormality of vitamin B metabolism (HP:0004340) | 1.84766358 |
| 143 | Lissencephaly (HP:0001339) | 1.84000506 |
| 144 | Pigmentary retinal degeneration (HP:0001146) | 1.83465163 |
| 145 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.83092310 |
| 146 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82534737 |
| 147 | Abnormality of alanine metabolism (HP:0010916) | 1.82534737 |
| 148 | Hyperalaninemia (HP:0003348) | 1.82534737 |
| 149 | Short foot (HP:0001773) | 1.82512070 |
| 150 | Clumsiness (HP:0002312) | 1.82172548 |
| 151 | Esotropia (HP:0000565) | 1.81239259 |
| 152 | Abolished electroretinogram (ERG) (HP:0000550) | 1.81084071 |
| 153 | Focal dystonia (HP:0004373) | 1.80566753 |
| 154 | Torticollis (HP:0000473) | 1.79904415 |
| 155 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.78681357 |
| 156 | Incomplete penetrance (HP:0003829) | 1.78606151 |
| 157 | Acute encephalopathy (HP:0006846) | 1.78021576 |
| 158 | Hypoventilation (HP:0002791) | 1.77994430 |
| 159 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77871985 |
| 160 | Gait ataxia (HP:0002066) | 1.77692731 |
| 161 | Postaxial foot polydactyly (HP:0001830) | 1.77274511 |
| 162 | Increased CSF lactate (HP:0002490) | 1.76731239 |
| 163 | Anencephaly (HP:0002323) | 1.76625299 |
| 164 | Methylmalonic acidemia (HP:0002912) | 1.76596605 |
| 165 | Mesangial abnormality (HP:0001966) | 1.76405080 |
| 166 | Male pseudohermaphroditism (HP:0000037) | 1.76364865 |
| 167 | Lower limb muscle weakness (HP:0007340) | 1.75432373 |
| 168 | Type II lissencephaly (HP:0007260) | 1.73667386 |
| 169 | Stereotypic behavior (HP:0000733) | 1.73219383 |
| 170 | Postural tremor (HP:0002174) | 1.72701990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.35322255 |
| 2 | NTRK3 | 4.53353471 |
| 3 | EPHA4 | 3.93893719 |
| 4 | MAP4K2 | 3.83339994 |
| 5 | MAP3K9 | 3.42937916 |
| 6 | MAP3K4 | 3.40229261 |
| 7 | MAP2K7 | 3.26775151 |
| 8 | MAP3K12 | 3.23456308 |
| 9 | CASK | 3.06274630 |
| 10 | RIPK4 | 2.83692008 |
| 11 | TNIK | 2.67932607 |
| 12 | MST4 | 2.38894748 |
| 13 | MARK1 | 2.34868714 |
| 14 | MINK1 | 2.32134899 |
| 15 | PNCK | 2.27318561 |
| 16 | MAP2K4 | 2.19226659 |
| 17 | PLK2 | 2.12195345 |
| 18 | DAPK2 | 2.11386913 |
| 19 | GRK5 | 1.99999237 |
| 20 | GRK1 | 1.93291908 |
| 21 | ARAF | 1.74711462 |
| 22 | NUAK1 | 1.68099431 |
| 23 | DAPK1 | 1.66368167 |
| 24 | FGFR2 | 1.64104148 |
| 25 | MAPK13 | 1.61275202 |
| 26 | NTRK2 | 1.60883982 |
| 27 | KSR2 | 1.60406840 |
| 28 | STK38L | 1.56867464 |
| 29 | NTRK1 | 1.55418388 |
| 30 | PAK6 | 1.53484824 |
| 31 | WNK4 | 1.52512642 |
| 32 | STK3 | 1.51152882 |
| 33 | KSR1 | 1.48431680 |
| 34 | TAOK3 | 1.41655954 |
| 35 | MAP3K13 | 1.41077748 |
| 36 | PRPF4B | 1.38326270 |
| 37 | BMPR2 | 1.38193176 |
| 38 | PTK2B | 1.37437790 |
| 39 | NME1 | 1.34544440 |
| 40 | MAPKAPK3 | 1.32252961 |
| 41 | CDK5 | 1.31618028 |
| 42 | CDK19 | 1.29142180 |
| 43 | IRAK1 | 1.24290225 |
| 44 | PRKCG | 1.23927417 |
| 45 | ZAK | 1.22461000 |
| 46 | CAMK2A | 1.19732196 |
| 47 | SIK2 | 1.18367443 |
| 48 | ACVR1B | 1.17453811 |
| 49 | EIF2AK1 | 1.16746152 |
| 50 | FES | 1.15950635 |
| 51 | IRAK2 | 1.11906211 |
| 52 | OXSR1 | 1.01291188 |
| 53 | ERBB3 | 0.97217715 |
| 54 | CAMK2B | 0.96717341 |
| 55 | CSNK1G1 | 0.96458008 |
| 56 | BRSK2 | 0.94120393 |
| 57 | MAPK15 | 0.91692653 |
| 58 | AKT3 | 0.91628733 |
| 59 | SGK2 | 0.87864259 |
| 60 | SGK223 | 0.87160084 |
| 61 | SGK494 | 0.87160084 |
| 62 | LATS2 | 0.85425776 |
| 63 | FGR | 0.84560083 |
| 64 | MAP3K6 | 0.84111654 |
| 65 | SIK3 | 0.83898453 |
| 66 | CAMKK1 | 0.83420218 |
| 67 | BRAF | 0.81722578 |
| 68 | NEK1 | 0.78524135 |
| 69 | MAP2K6 | 0.77880026 |
| 70 | CAMKK2 | 0.76564883 |
| 71 | CSNK1G3 | 0.74531247 |
| 72 | TXK | 0.74362232 |
| 73 | CDK14 | 0.72487019 |
| 74 | CCNB1 | 0.72309682 |
| 75 | STK38 | 0.71658168 |
| 76 | PRKCE | 0.71641565 |
| 77 | PHKG2 | 0.71637151 |
| 78 | PHKG1 | 0.71637151 |
| 79 | DYRK1A | 0.71483824 |
| 80 | BCR | 0.70658510 |
| 81 | SGK1 | 0.70266798 |
| 82 | MAP3K2 | 0.69663464 |
| 83 | CAMK1 | 0.69385983 |
| 84 | RAF1 | 0.69182388 |
| 85 | CDK18 | 0.68551786 |
| 86 | UHMK1 | 0.66972228 |
| 87 | CSNK1G2 | 0.64847859 |
| 88 | CAMK2D | 0.62897795 |
| 89 | CDK15 | 0.62481932 |
| 90 | MAP3K1 | 0.60211120 |
| 91 | PAK3 | 0.60041724 |
| 92 | GRK6 | 0.58421123 |
| 93 | VRK1 | 0.57418000 |
| 94 | MKNK2 | 0.55466448 |
| 95 | FER | 0.55166171 |
| 96 | OBSCN | 0.54657264 |
| 97 | STK24 | 0.54291336 |
| 98 | PRKD3 | 0.53661336 |
| 99 | STK11 | 0.53462922 |
| 100 | RET | 0.52957830 |
| 101 | CDK11A | 0.52057289 |
| 102 | PRKAA1 | 0.51501539 |
| 103 | PLK4 | 0.51080238 |
| 104 | EIF2AK3 | 0.50374812 |
| 105 | MUSK | 0.50251727 |
| 106 | PRKCI | 0.49716834 |
| 107 | YES1 | 0.49537721 |
| 108 | CAMK2G | 0.49162992 |
| 109 | CDK3 | 0.49133372 |
| 110 | SGK3 | 0.49064743 |
| 111 | PINK1 | 0.47718261 |
| 112 | CSNK1A1 | 0.46991163 |
| 113 | ADRBK2 | 0.46916065 |
| 114 | ADRBK1 | 0.46025956 |
| 115 | TNK2 | 0.45659479 |
| 116 | STK39 | 0.43460011 |
| 117 | MAP2K1 | 0.43272886 |
| 118 | NLK | 0.43146262 |
| 119 | ROCK2 | 0.42990972 |
| 120 | PLK3 | 0.42446391 |
| 121 | PRKCH | 0.41613134 |
| 122 | PKN1 | 0.41146659 |
| 123 | WNK3 | 0.40081821 |
| 124 | PRKG2 | 0.39268055 |
| 125 | PRKCQ | 0.39129036 |
| 126 | PRKCA | 0.38771064 |
| 127 | DYRK2 | 0.38374632 |
| 128 | PDK1 | 0.38363806 |
| 129 | PRKACA | 0.38251554 |
| 130 | TAOK1 | 0.38105389 |
| 131 | CSNK1D | 0.37648298 |
| 132 | ITK | 0.37558042 |
| 133 | TRPM7 | 0.37537700 |
| 134 | PRKCZ | 0.37513920 |
| 135 | ERBB2 | 0.37279930 |
| 136 | MAP3K7 | 0.37163430 |
| 137 | MARK2 | 0.36855812 |
| 138 | INSRR | 0.36560721 |
| 139 | CSNK1A1L | 0.36422148 |
| 140 | PDPK1 | 0.36275137 |
| 141 | GRK7 | 0.36249745 |
| 142 | PRKAA2 | 0.34089247 |
| 143 | TSSK6 | 0.33595945 |
| 144 | CHUK | 0.33430997 |
| 145 | RPS6KA3 | 0.32438822 |
| 146 | FYN | 0.32365893 |
| 147 | PRKACB | 0.31749037 |
| 148 | CAMK1G | 0.31729200 |
| 149 | PRKCB | 0.31642667 |
| 150 | ROCK1 | 0.31587090 |
| 151 | BMPR1B | 0.30410765 |
| 152 | PRKG1 | 0.29712499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.34288717 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.58659325 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.19257539 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.97411246 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73786767 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70068308 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.63740559 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.56880388 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.54806154 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50099978 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46726755 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.43896322 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.43789153 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.25386004 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22052751 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.20060148 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 2.03951863 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.02076255 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92438851 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88528282 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.88253521 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.85734291 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73447858 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.70205434 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.68414504 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68265036 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67554197 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58252743 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58078295 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57970815 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53370128 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52975626 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48870597 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.47930624 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47229314 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44293721 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.42026225 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40670729 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39590568 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.39183896 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38045991 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37253930 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36910035 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.36168233 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33834131 |
| 46 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33729267 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30783674 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30159557 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.29494471 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28029782 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26643023 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26122026 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24932056 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.22064505 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.21699357 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19311232 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 1.11716071 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 1.11536014 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10579231 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 1.09805135 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08888688 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08343411 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06213197 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05205039 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00779773 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99233028 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97418616 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96930480 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.95691788 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95591610 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94154821 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.93794486 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93064521 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91448347 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90179775 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89656512 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89599655 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87754779 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85474419 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.84635250 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83102296 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81930563 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81214858 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77425650 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75259268 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74619845 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73068629 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72787687 |
| 89 | Homologous recombination_Homo sapiens_hsa03440 | 0.70147540 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69610856 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67155312 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66932207 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64745147 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60829318 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60470452 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60134297 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59946058 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58963014 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58389532 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58250598 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56932105 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56249818 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54896590 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54599317 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53790369 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53304492 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52008679 |
| 108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51930684 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51564828 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50910882 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50807133 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.50804242 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48011903 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44906209 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44536048 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44079693 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.43592658 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.42899001 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41904617 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41744329 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.41343125 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40360116 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39912941 |
| 124 | RNA polymerase_Homo sapiens_hsa03020 | 0.39875325 |
| 125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38954493 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38750236 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.38630263 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.38495275 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38198728 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37568759 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36687795 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.34791845 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34597580 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34106480 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34017828 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.33328537 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32708351 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32688338 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29869914 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28146343 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27456893 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26894355 |
| 143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25611474 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24906361 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.21684885 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18110621 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17791228 |
| 148 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.16988729 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16516018 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15740674 |

